Loading asset research
YD Bio Limited Ordinary Shares
YDESNasdaq · USD · StocksQuote as of · Exchange session not verified$4.00
+2.56%
Today
YDES
Loading 1D prices…
Market cap
$283.3M
Volume
819.3K
52w high
$23.0052w low
$1.70Company profile
YD Bio Limited Ordinary Shares
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Sector
Health Care
Industry
Services-Medical Laboratories
Exchange
Nasdaq
Display currency
USD
Location
Taipei, TX, United States
Fiscal year end
1231
CIK
2011674
Session & valuation
Open$3.93
Previous close$3.90
Day high$4.19
Day low$3.61
30-day avg. volume218.2K
Outstanding shares70.8M
Diluted EPS-$0.12
Latest annual period
P/E (trailing)-33.33
P/E (forward)—
Price / book0.88
Beta-0.03
Dividend yield—
Deterministic peer set
Companies with SEC SIC 8071
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BDSXBiodesix Inc. Common Stock | $284.5M | $88.5M | -39.85% | -$4.67 | +3.30% | Buy |
| XGNExagen Inc. Common Stock | $170.3M | $66.6M | -29.97% | -$0.93 | +0.86% | Buy |
| FLGTFulgent Genetics Inc. Common Stock | $562.7M | $322.7M | -18.75% | -$1.97 | +0.75% | Hold |
| BNRBurning Rock Biotech Limited American Depositary Shares | $129.5M | $77.2M | -10.26% | -$5.10 | +5.68% | Unrated |
| CSTLCastle Biosciences Inc. Common Stock | $987.7M | $344.2M | -7.02% | -$0.83 | -0.03% | Buy |